Cargando…
Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
BACKGROUND: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646768/ https://www.ncbi.nlm.nih.gov/pubmed/23667599 http://dx.doi.org/10.1371/journal.pone.0063273 |
_version_ | 1782268640759906304 |
---|---|
author | Moodley, Dhayendre Reddy, Leanne Mahungo, Wisani Masha, Rebotile |
author_facet | Moodley, Dhayendre Reddy, Leanne Mahungo, Wisani Masha, Rebotile |
author_sort | Moodley, Dhayendre |
collection | PubMed |
description | BACKGROUND: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until the child is confirmed HIV-uninfected and there is no further exposure to breastmilk transmission. We determined CTX coverage and explored factors associated with CTX administration in HIV-exposed infants at a primary health clinic in South Africa. METHODS: In a cross-sectional study of HIV-exposed infants 6–18 months of age attending a child immunisation clinic, data from the current visit and previous visits related to CTX prophylaxis, feeding practice and infant HIV testing were extracted from the child's immunisation record. Further information related to the administration of CTX prophylaxis was obtained from an interview with the child's mother. RESULTS: One-third (33.0%) HIV-exposed infants had not initiated CTX at all and breastfed infants were more likely to have commenced CTX prophylaxis as compared to their non-breastfed counterparts (78.7% vs 63.4%) (p = 0.008). Availability of infant's HIV status was strongly associated with continuation or discontinuation of CTX after 6 months of age or after breastfeeding cessation. Maternal self-reports indicated that only 52.5% (95%CI 47.5–57.5) understood the reason for CTX prophylaxis, 126 (47%) did not dose during weekends; 55 (21%) dosed their infants 3 times a day and 70 (26%) dosed their infants twice daily. CONCLUSION: A third of HIV-exposed children attending a primary health care facility in this South African setting did not receive CTX prophylaxis. Not commencing CTX prophylaxis was strongly associated with infants not breastfeeding and unnecessary continued exposure to CTX in this paediatric population was due to limited availability of early infant diagnosis. Attendance at immunization clinics can be seen as missed opportunities for early infant diagnosis of HIV and related care. |
format | Online Article Text |
id | pubmed-3646768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36467682013-05-10 Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa Moodley, Dhayendre Reddy, Leanne Mahungo, Wisani Masha, Rebotile PLoS One Research Article BACKGROUND: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until the child is confirmed HIV-uninfected and there is no further exposure to breastmilk transmission. We determined CTX coverage and explored factors associated with CTX administration in HIV-exposed infants at a primary health clinic in South Africa. METHODS: In a cross-sectional study of HIV-exposed infants 6–18 months of age attending a child immunisation clinic, data from the current visit and previous visits related to CTX prophylaxis, feeding practice and infant HIV testing were extracted from the child's immunisation record. Further information related to the administration of CTX prophylaxis was obtained from an interview with the child's mother. RESULTS: One-third (33.0%) HIV-exposed infants had not initiated CTX at all and breastfed infants were more likely to have commenced CTX prophylaxis as compared to their non-breastfed counterparts (78.7% vs 63.4%) (p = 0.008). Availability of infant's HIV status was strongly associated with continuation or discontinuation of CTX after 6 months of age or after breastfeeding cessation. Maternal self-reports indicated that only 52.5% (95%CI 47.5–57.5) understood the reason for CTX prophylaxis, 126 (47%) did not dose during weekends; 55 (21%) dosed their infants 3 times a day and 70 (26%) dosed their infants twice daily. CONCLUSION: A third of HIV-exposed children attending a primary health care facility in this South African setting did not receive CTX prophylaxis. Not commencing CTX prophylaxis was strongly associated with infants not breastfeeding and unnecessary continued exposure to CTX in this paediatric population was due to limited availability of early infant diagnosis. Attendance at immunization clinics can be seen as missed opportunities for early infant diagnosis of HIV and related care. Public Library of Science 2013-05-07 /pmc/articles/PMC3646768/ /pubmed/23667599 http://dx.doi.org/10.1371/journal.pone.0063273 Text en © 2013 Moodley et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Moodley, Dhayendre Reddy, Leanne Mahungo, Wisani Masha, Rebotile Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa |
title | Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa |
title_full | Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa |
title_fullStr | Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa |
title_full_unstemmed | Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa |
title_short | Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa |
title_sort | factors associated with coverage of cotrimoxazole prophylaxis in hiv-exposed children in south africa |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646768/ https://www.ncbi.nlm.nih.gov/pubmed/23667599 http://dx.doi.org/10.1371/journal.pone.0063273 |
work_keys_str_mv | AT moodleydhayendre factorsassociatedwithcoverageofcotrimoxazoleprophylaxisinhivexposedchildreninsouthafrica AT reddyleanne factorsassociatedwithcoverageofcotrimoxazoleprophylaxisinhivexposedchildreninsouthafrica AT mahungowisani factorsassociatedwithcoverageofcotrimoxazoleprophylaxisinhivexposedchildreninsouthafrica AT masharebotile factorsassociatedwithcoverageofcotrimoxazoleprophylaxisinhivexposedchildreninsouthafrica |